1. Home
  2. PBYI vs HBB Comparison

PBYI vs HBB Comparison

Compare PBYI & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • HBB
  • Stock Information
  • Founded
  • PBYI 2010
  • HBB 1904
  • Country
  • PBYI United States
  • HBB United States
  • Employees
  • PBYI N/A
  • HBB N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • HBB Home Furnishings
  • Sector
  • PBYI Health Care
  • HBB Consumer Discretionary
  • Exchange
  • PBYI Nasdaq
  • HBB Nasdaq
  • Market Cap
  • PBYI 237.2M
  • HBB 196.2M
  • IPO Year
  • PBYI N/A
  • HBB 2017
  • Fundamental
  • Price
  • PBYI $5.41
  • HBB $15.36
  • Analyst Decision
  • PBYI Strong Buy
  • HBB
  • Analyst Count
  • PBYI 1
  • HBB 0
  • Target Price
  • PBYI $7.00
  • HBB N/A
  • AVG Volume (30 Days)
  • PBYI 511.9K
  • HBB 28.1K
  • Earning Date
  • PBYI 11-06-2025
  • HBB 10-29-2025
  • Dividend Yield
  • PBYI N/A
  • HBB 3.13%
  • EPS Growth
  • PBYI 434.29
  • HBB N/A
  • EPS
  • PBYI 0.97
  • HBB 2.35
  • Revenue
  • PBYI $238,062,000.00
  • HBB $631,318,000.00
  • Revenue This Year
  • PBYI N/A
  • HBB N/A
  • Revenue Next Year
  • PBYI N/A
  • HBB N/A
  • P/E Ratio
  • PBYI $5.56
  • HBB $6.47
  • Revenue Growth
  • PBYI 8.63
  • HBB N/A
  • 52 Week Low
  • PBYI $2.32
  • HBB $12.72
  • 52 Week High
  • PBYI $6.07
  • HBB $31.78
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 65.34
  • HBB 57.91
  • Support Level
  • PBYI $5.11
  • HBB $13.80
  • Resistance Level
  • PBYI $5.42
  • HBB $15.53
  • Average True Range (ATR)
  • PBYI 0.25
  • HBB 0.58
  • MACD
  • PBYI 0.06
  • HBB 0.13
  • Stochastic Oscillator
  • PBYI 75.36
  • HBB 85.29

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.

Share on Social Networks: